Use of Flozins (Empagliflozin/Dapagliflozin) for Prevention of AKI — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Use of Flozins (Empagliflozin/Dapagliflozin) for Prevention of AKI — Stella

Home/Coronary Artery Disease/

View on ClinicalTrials.gov

Recruiting

Back to Coronary Artery Disease trials

Trial locations(1 site)

Poland

Collegium Medicum w Bydgoszczy, Bydgoszcz

Key details

Sponsor

Collegium Medicum w Bydgoszczy

Enrollment target

~4,000 participants

Started

November 2025

Primary completion

December 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated November 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.